| Firm | Analyst |
|---|---|
| Baird | Catherine Schulte |
| BofA Securities | Michael Ryskin |
| Craig-Hallum | Matt Hewitt |
| Deutsche Bank | Justin Bowers |
| Goldman Sachs | Matthew Sykes |
| Guggenheim Securities | Subbu Nambi |
| Jefferies | Matt Stanton |
| KeyBanc | Paul Knight |
| Morgan Stanley | Tejas Savant |
| RBC Capital Markets | Conor McNamara |
| Stifel | Dan Arias |
| UBS | Dan Leonard |
| Wells Fargo | Brandon Coulliard |
| William Blair | Matt Larew |
| Wolfe Research | Doug Schenkel |
Maravai LifeSciences Holdings, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Maravai LifeSciences Holdings, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Maravai LifeSciences Holdings, Inc. or its management. Maravai LifeSciences Holdings, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.